Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to guinea-pig platelets
- 1 November 1986
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 131 (1) , 49-54
- https://doi.org/10.1016/0014-2999(86)90514-5
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- A novel approach for the study of thromboxane A2 and prostaglandin H2 receptors using an 125I-labeled ligandBiochemical Pharmacology, 1985
- Synthesis of thromboxane receptor antagonists with the potential to radiolabel with 125ITetrahedron Letters, 1984
- Ligand binding to thromboxane receptors on human platelets: correlation with biological activityBritish Journal of Pharmacology, 1983
- Arachidonate induced aggregation of rat platelets may not require prostaglandin endoperoxides or thromboxane A2Thrombosis Research, 1983
- Responsiveness of platelets and coronary arteries from different species to synthetic thromboxane and prostaglandin endoperoxide analoguesBritish Journal of Pharmacology, 1983
- Specific binding of the thromboxane A2 antagonist 13-azaprostanoic acid to human platelet membranesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1983
- Epoprostenol (prostacyclin, PGI2) binding and activation of adenylate cyclase in platelets of diabetic and control subjects.British Journal of Clinical Pharmacology, 1983
- Effect of agents that alter cyclic AMP on arachidonate-induced platelet aggregation in the dogBlood, 1980
- Scatchard plots: Common errors in correction and interpretationSteroids, 1975
- Isolation and Structure of Two Prostaglandin Endoperoxides That Cause Platelet AggregationProceedings of the National Academy of Sciences, 1974